drugset / Trial / NCT00502632
Dornase Alfa and Urokinase for Kids With Pleural Empyema
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether intrapleural treatment with Dornase alfa plus Urokinase improves clinical outcome compared to Urokinase alone in children with complicated parapneumonic effusions
Timeline
- Start
- 2007-10
- Primary completion
- —
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dornase alfa | Protein / enzyme biologic | 2500 iu | Other |
| Background | Urokinase | Protein / enzyme biologic | 40000 unknown | Other |